Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-22

Clinical Trial Update: Postpartum Low-Dose Aspirin and Preeclampsia [Phase 2]

View source ↗

Summary

This update notes a Phase 2 clinical trial is recruiting to evaluate postpartum low-dose aspirin for prevention of preeclampsia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aspirin (Aspirin)

Snippet

Sponsor: Columbia University | Conditions: Preeclampsia Postpartum | Phase 2 | Status: RECRUITING